Drug Database
Back to search

France· FR:66274639

LOMUSTINE MEDAC 40 mg, gélule

A lomustine product containing lomustine, registered in France by MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE). The same ATC class is registered in 10 of our 19 countries.

ATC L01AD02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLOMUSTINE MEDAC 40 mg, géluleATCL01AD02REGISTER NO.FR:66274639PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lomustineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lomustine is registered in 10 of 19 countries.

Countries holding a registration under ATC L01AD02 (lomustine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 4 of them publish a price we can compare per daily dose
Search lomustine products by name

Lomustine · ATC L01AD02

10 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LOMUSTINE
Manufacturer
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
Country
France (FR)
ATC code
L01AD02
ATC class
Lomustine
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930271193
    1 flacon(s) en plastique avec fermeture de sécurité de 5 gélule(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

166 interactions on record for lomustine.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lomustine against other medicinesHow interaction checks work

Lomustine · interactions on record

166 records

  • 36 severe
  • 112 moderate
  • 18 minor

Most severe, free to view

  • CimetidineA02BA01severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Nalidixic acidJ01MB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lomustine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lomustine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Lomustin (Ccnu) Medac
  • Germany · Cecenu®
  • Denmark · Lomustine Medac
  • Finland · Lomustine Medac
  • United Kingdom (Northern Ireland) · Lomustine Medac
  • Sweden · Lomustine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6372d99e-7d1c-4fdf-a8e0-ee3e6639be8b
GET /v1/drugs/6372d99e-7d1c-4fdf-a8e0-ee3e6639be8b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66274639",
  "date_amm": "2022-12-08",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "LOMUSTINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about lomustine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console